Quinolinate

Sample type: Urine
Optimal result: 0 – 5.37 ug/mg creatinine

High levels of quinolinate may occur when there are nutritional enzyme inhibitions of the breakdown pathways, inherited low-activity enzymes are present, if there are high levels of precursors (tryptophan or 5-HTP), or if there are higher levels of its downstream products. Only about 5% of tryptophan is converted into serotonin, the rest is excreted or used in the kynurenine pathway to synthesize NAD+, a necessary cofactor in over 200 biochemical reactions. Quinolinate levels can increase if there are downstream blocks on the NAD+ synthesis pathway. Chronic systemic inflammation may divert tryptophan down the kynurenate metabolic pathway and raise quinolinate levels. Quinolinate can bind with receptors in the central nervous system (NMDA and α-7 nicotinic acetycholine receptors) and increase their activity which can contribute to glutamate neurotoxicity. Higher quinolinate levels can contribute to neuroinflammation and predispose for psychological, behavioral, or neurodegenerative disorders. If quinolinate levels are higher than kynurenate levels, then systemic or neuroinflammation is likely and the patient may need additional antioxidants and other supports. A higher ratio of brain kynurenate/quinolinate is considered neuroprotective in various neurological conditions. Phthalate exposure may increase quinolinate levels and disrupt tryptophan metabolism.

- The interconversion of lactate and pyruvate is NAD+ dependent; review both analytes for clues about NAD+ status. If appropriate, consider newer NAD+ precursors such as nicotinamide riboside, which may bypass NAD+ synthesis pathway blocks and promote the synthesis of protective compounds during NAD+ synthesis with vitamin B6 and zinc.

- Quinolinate levels have been associated with levels of the inflammatory biomarker serum CRP. Chronic inflammation may be due to or exacerbated by undiagnosed allergy or sensitivity to environmental aeroallergens, foods or molds. If indicated by patient symptoms or history, consider testing for environmental or food allergy/sensitivity with US BIOTEK IgG, IgA, IgE and IgG4 profiles.

- If inflammation is present, consider anti-inflammatory therapies to down-regulate the inflammatory branch of the kynurenine pathway. Anti-inflammatory agents may include curcumin, melatonin, pycnogenol, N-acetyl cysteine (NAC), glutathione, etc.

Low levels of quinolinate may occur if there are low levels of precursors (tryptophan), if there are nutritional enzyme inhibitions, or if a low-activity enzyme variant is inherited. Only about 5% of tryptophan is converted into serotonin, the rest is excreted or used in the kynurenine pathway to synthesize NAD+, a necessary cofactor in over 200 biochemical reactions. Quinolinate levels can decrease if there are low levels of circulating tryptophan or if there are upstream blocks on the NAD+ synthesis pathway.

- If appropriate, consider supporting the NAD+ synthesis pathway with vitamins B2, B3, B6, and iron (if deficient). The interconversion of lactate and pyruvate is NAD+ dependent; review both analytes for clues about NAD+ status.

- Low levels of tryptophan absorption may occur if digestive disorders are present or if a low-protein diet is used. If indicated, consider providing tryptophan between meals on an empty stomach to improve absorption. Levels of kynurenate, 5-hydroxyindoleacetate, and 3-indoleacetate may be low if tryptophan levels are low.

Quinolinic acid is a neurotoxic substance produced by our own bodies and a metabolite of tryptophan.

Tryptophan and its different pathways:

The management of tryptophan converting to serotonin within the brain has some complex moving parts. Tryptophan gets converted into serotonin. High levels of stress of any type and acute/chronic infections can change this process by provoking an immune system response. Instead of serotonin being made from tryptophan in this process, two other compounds are eventually made: They are kynurenic acid which is neuroprotective and quinolinic acid which is neurodegenerative.The quinolinic acid is a NMDA-agonist, i.e. quinolinic acid, NMDA, and inflammation are best friends and like to wreak havoc when kynurenic acid is lacking. Recent research showed that patients suffering from severe depression and suicidality were found to have very high levels of inflammation and elevated NMDA activity as a result of long-term dysregulation of this pathway. The researchers’ recommended goal was to find ways to dampen the NMDA receptors and quinolinic acid in the brain.

Quinolinic acid is a neurotoxic substance produced by our own bodies and a metabolite of tryptophan.

Tryptophan and its different pathways:

The management of tryptophan converting to serotonin within the brain has some complex moving parts. Tryptophan gets converted into serotonin. High levels of stress of any type and acute/chronic infections can change this process by provoking an immune system response. Instead of serotonin being made from tryptophan in this process, two other compounds are eventually made: They are kynurenic acid which is neuroprotective and quinolinic acid which is neurodegenerative.The quinolinic acid is a NMDA-agonist, i.e. quinolinic acid, NMDA, and inflammation are best friends and like to wreak havoc when kynurenic acid is lacking. Recent research showed that patients suffering from severe depression and suicidality were found to have very high levels of inflammation and elevated NMDA activity as a result of long-term dysregulation of this pathway. The researchers’ recommended goal was to find ways to dampen the NMDA receptors and quinolinic acid in the brain.

Treatment:

The cause of inflammation needs to be treated. Simply taking SSRI drugs (Selective serotonin reuptake inhibitors) to make more serotonin further downstream is not going to work. The drug use and application generally fails to address the inflammation. The drugs simply try to increase the amount of serotonin within the system at the synapses, but the underlying damaging inflammation is still ongoing. This process also affects cognitive health, which has great implications for all neurodegenerative concerns. When the brain is on fire with inflammation leading to depression, anxiety, sleep problems, cognitive changes, it has to be thoroughly addressed. SSRIs miss this inflammatory aspect.

Resources:

NMDA receptor function, memory, and brain aging (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181613/)

A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. (https://www.ncbi.nlm.nih.gov/pubmed/8293279)

Sulforaphane reduces the alterations induced by quinolinic acid: Modulation of glutathione levels (https://www.researchgate.net/publication/262569040_Sulforaphane_reduces_the_alterations_induced_by_quinolinic_acid_Modulation_of_glutathione_levels)

Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies. (https://www.ncbi.nlm.nih.gov/pubmed/12871589)

Melatonin neutralizes neurotoxicity induced by quinolinic acid in brain tissue culture. (https://www.ncbi.nlm.nih.gov/pubmed/16150107)

Neuroprotective potential of L-theanine against excitotoxic neuronal death induced by quinolinic acid: Possible neurotransmitters and nitric oxide modulation mechanism (http://www.mdsabstracts.org/abstract/neuroprotective-potential-of-l-theanine-against-excitotoxic-neuronal-death-induced-by-quinolinic-acid-possible-neurotransmitters-and-nitric-oxide-modulation-mechanism/)

Green Tea Polyphenols Decrease Enzyme Activity of Nitric Oxide Synthase, https://www.fasebj.org/doi/abs/10.1096/fasebj.27.1_supplement.790.14

Neuroprotective Activity of Curcumin in Combination with Piperine against Quinolinic Acid Induced Neurodegeneration in Rats (https://www.karger.com/Article/PDF/443896)

Quinolinate
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Quinolinate — 10,000+ markers explained
One Quinolinate result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro